Literature DB >> 20977688

Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma.

B Spangler1, L Vardimon, A K Bosserhoff, S Kuphal.   

Abstract

A central event in the development of malignant melanoma is the loss of the tumor-suppressor protein E-cadherin. Here, we report that this loss is linked to the activation of the proto-oncogene c-Jun, a key player in tumorigenesis. In vivo, malignant melanomas show strong expression of the c-Jun protein in contrast to melanocytes. Interestingly, c-Jun mRNA levels did not differ in the melanoma cell lines when compared to melanocytes, suggesting that c-Jun could be regulated at the post-transcriptional level. To uncover the link between E-cadherin and c-Jun, we re-expressed E-cadherin in melanoma cells and detected decreased protein expression and activity of c-Jun. Furthermore, c-Jun accumulation is dependent on active E-cadherin-mediated cell-cell adhesion and regulated via the cytoskeleton. Additionally, we determined that, with respect to c-Jun regulation, there are two melanoma subgroups. One subgroup regulates c-Jun expression via the newly discovered E-cadherin-dependent signaling pathway, whereas the other subgroup uses the MAPKinases to regulate its expression. In summary, our data provide novel insights into the tumor-suppressor function of E-cadherin, which contributes to the suppression of c-Jun protein translation and transcriptional activity independent of MAPKinases.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977688     DOI: 10.1111/j.1755-148X.2010.00787.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  20 in total

1.  Specific c-Jun target genes in malignant melanoma.

Authors:  Patrick Schummer; Silke Kuphal; Lily Vardimon; Anja K Bosserhoff; Melanie Kappelmann
Journal:  Cancer Biol Ther       Date:  2016-04-06       Impact factor: 4.742

2.  Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation.

Authors:  Lior Blau; Revital Knirsh; Iris Ben-Dror; Sivan Oren; Silke Kuphal; Peter Hau; Martin Proescholdt; Anja-Katrin Bosserhoff; Lily Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

3.  Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.

Authors:  Xiao-Fei Song; Qi-Hua Wang; Ran Huo
Journal:  Pathol Oncol Res       Date:  2017-11-14       Impact factor: 3.201

4.  The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.

Authors:  K Maurus; A Hufnagel; F Geiger; S Graf; C Berking; A Heinemann; A Paschen; S Kneitz; C Stigloher; E Geissinger; C Otto; A Bosserhoff; M Schartl; S Meierjohann
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

5.  Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling.

Authors:  Maren Eckey; Silke Kuphal; Tobias Straub; Petra Rümmele; Elisabeth Kremmer; Anja K Bosserhoff; Peter B Becker
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

6.  Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model.

Authors:  Masanobu Tsubaki; Tomoya Takeda; Toshiki Kino; Naoya Obata; Tatsuki Itoh; Motohiro Imano; Kenji Mashimo; Daichiro Fujiwara; Katsuhiko Sakaguchi; Takao Satou; Shozo Nishida
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

7.  Expression of connexin 43 and E-cadherin in choroidal melanoma.

Authors:  Ying-Ying Mou; Gui-Qiu Zhao; Jin-Yong Lin; Jie Zhao; Hong Lin; Li-Ting Hu; Qiang Xu; Qing Wang; Wei-Rong Sun
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

8.  Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma.

Authors:  Jan Rožanc; Theodore Sakellaropoulos; Asier Antoranz; Cristiano Guttà; Biswajit Podder; Vesna Vetma; Nicole Rufo; Patrizia Agostinis; Vaia Pliaka; Thomas Sauter; Dagmar Kulms; Markus Rehm; Leonidas G Alexopoulos
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

9.  HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.

Authors:  Michael F Emmons; Fernanda Faião-Flores; Ritin Sharma; Ram Thapa; Jane L Messina; Jurgen C Becker; Dirk Schadendorf; Edward Seto; Vernon K Sondak; John M Koomen; Yian A Chen; Eric K Lau; Lixin Wan; Jonathan D Licht; Keiran S M Smalley
Journal:  Cancer Res       Date:  2019-04-15       Impact factor: 12.701

10.  Increased expression of c-Jun in nonalcoholic fatty liver disease.

Authors:  Christoph Dorn; Julia C Engelmann; Michael Saugspier; Andreas Koch; Arndt Hartmann; Martina Müller; Rainer Spang; Anja Bosserhoff; Claus Hellerbrand
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.